Hysterectomy and oophorectomy experiences of female-to-male transgender individuals

International Journal of Transgenderism

Volumn 12, Issue 3, 2010, Pages 155-166

  Rachlin, Katherine ^a   Hansbury, Griffin ^a   Pardo, Seth T ^b  

^a Cornell University ^*

^b Department of Obstetrics Gynecology   (United States)

Author keywords

Female to male; Ftm; Gender identity; Hysterectomy; Sex reassignment surgery; Standards of care; Testosterone; Transgender; Transman; Transsexual

Indexed keywords

EID: 77957917522     PISSN: 15532739     EISSN: 14344599     Source Type: Journal    
DOI: 10.1080/15532739.2010.514220     Document Type: Article

References (47)

1. Baba, T., Endo, T., Honnma, H., Kitajima, Y., Hayashi, T., Ikeda, H., et al. (2007). Association between polycystic ovary syndrome and female-to-male transsexuality. Human Reproduction, 22, 1011-1016.
2. Balen, A. H., Schachter, M. E., Montgomery, D., Reid, R. W., & Jacob, H. S. (1993). Polycystic ovaries are a common finding in untreated female-to-male transsexuals. Clinical Endocrinology, 38, 325-329.
3. Barrett, J. (1998). Psychological and social function before and after phalloplasty. International Journal of Transgenderism, 2. Retrieved June 16, 2005, from http://www.symposion.com/ijt/
4. Bartos, P., Struppl, D., & Popelka, P. (2001). Role of total laparoscopic hysterectomy in genital reconstruction in transsexuals. Ceska gynekologie, 66, 193-195.
5. Bockting, W. O., Knudson, G., & Goldberg, J. M. (2006). Counseling and mental health care for transgender adults and loved ones. In W. O. Bockting & J. M. Goldberg (Eds.), Guidelines for Transgender Care (pp. 35-82). Binghamton, NY: Haworth Medical Press.
6. Cameron, B., & Goldberg, J. M. (2006). Care of the patient undergoing sex reassignment surgery. International Journal of Transgenderism, 9, 135-165.
7. Chapin, D. S. (1993). Laparoscopically assisted vaginal hysterectomy in female-to-male transsexuals [Letter]. Plastic and Reconstructive Surgery, 91, 962.
8. Cramer,D.W.,&Missmer, S.A. (2002). The epidemiology of endometriosis. Gynecologic and Obstetric Investigation, 53, 2-11.
9. Cromwell, J. (1999). Transmen and FTMs: Identities, bodies, genders and sexualities. Urbana, IL: University of Illinois Press.
10. Dahl, M., Feldman, J. L., Goldberg, J. M., & Jaberi, A. (2006). Physical aspects of transgender endocrine therapy. International Journal of Transgenderism, 9, 111-134.
11. Devor, H. (1997). FTM: Female-to-male transsexuals in society. Bloomington, IN: Indiana University Press.
12. Ergeneli, M. H., Duran, E. H., Özcan, G., & Erdogan, M. (1999). Vaginectomy and laparoscopically assisted vaginal hysterectomy as adjunctive surgery for femaleto-male transsexual reassignment: Preliminary report. European Journal of Obstetrics & Gynecology and Reproductive Biology, 87, 35-37.
13. Feldman, J. L. (2007). Preventative care of the transgender patient: An evidence-based approach. In R. Ettner, S. Monstrey, & E. Eyler (Eds.), Principles of Transgender Medicine and Surgery (pp. 33-72). Binghamton, NY: Haworth Press.
14. Feldman, J. L., & Goldberg, J. (2006, January). Transgender primary medical care: Suggested guidelines for clinicians in British Columbia. Retrieved May 11, 2007, from http://www.vch.ca/transhealth/resources/library/tcpdocs/guidelines-primcare.pdf
15. Fleming, M. (1982). The body image of the postoperative female-to-male transsexual. Journal of Consulting and Clinical Psychology, 50, 461-462.
16. Futterweit, W. (1998). Endocrine therapy of transsexualism and potential complications of long-term treatment. Archives of Sexual Behavior, 27, 209-226.
17. Futterweit, W., & Deligdisch, L. (1986). Histopathological effects of exogenously administered testosterone in 19 female to male transsexuals. Journal of Clinical Endocrinology & Metabolism, 62, 16-21.
18. Gerli, S., Rossetti, D., Pacifici, A., Aviles, E., Dominici, C., Mattei, A., et al. (2001). Hysterectomy for the transsexual. Journal of theAmerican Association of Gynecologic Laparoscopists, 8, 613-614.
19. Green, J. (2003). Becoming a visible man. Nashville, TN: Vanderbilt University Press.
20. Hage, J. J., Dekker, J. J., Karim, R. B., Verheijen, R. H., & Bloemena, E. (2000). Ovarian cancer in female-tomale transsexuals: Report of two cases. Gynecologic oncology, 76, 413-415.
21. Hembree, W. C., Cohen-Kettenis, P., Delemarre-van de Waal, H. A., Gooren, L. J., Meyer, W. J., et al. (2009). Endocrine treatment of transsexual persons: An Endocrine Society clinical practice guideline. Retrieved January 11, 2010, from http://www.endo-society.org/guidelines/final/upload/Endocrine-Treatment-of-Transsexual-Persons.pdf
22. Hull, M. (1987). Epidemiology of infertility and polycystic ovarian disease: Endocrinological and demographic studies. Gynecology & Endocrinology, 1, 233-45.
23. Kotula, D. (2002). The phallus palace. Los Angeles: Alyson.
24. Lev, A. I. (2004). Transgender emergence: Therapeutic guidelines for working with gender variant people and their families. New York: Hawthorn Press.
25. Lev, A. I. (2009). Ten tasks of the mental health professional. International Journal of Transgenderism, 11, 74-99.
26. Levy, A., Crown, A., Reid, T. K., & Russell, T. K. (2003). Endocrine intervention for transsexuals. Clinical Endocrinology, 59, 409-418.
27. Lothstein, L. M. (1983). Female-to-male transsexualism: Historical, clinical and theoretical issues. Boston: Routledge & Kegan Paul.
28. Meyer, W., Bockting, W. O., Cohen-Kettenis, P., Coleman, E., DiCeglie, D., Devor, H., et al. (2001). The Harry Benjamin Gender Dysphoria Association's standards of care for gender identity disorders, sixth version. Journal of Psychology & Human Sexuality, 13, 1-30.
29. Michel, A., Mormont, C., & Legros, J. J. (2001). A psychoendocrinological overviewof transsexualism. European Journal of Endocrinology, 145, 365-76.
30. Miller, N., Bedard, Y. C., Cooter, N. B., & Shaul, D. L. (1986).Histological changes in the genital tract in transsexual women following androgen therapy. Histology, 10, 661-669.
31. Monstrey, S., Ceulemans, P., & Hoebeke, P. (2007). Surgery: Female-to-male patient. In R. Ettner, S. Monstrey, & E. Eyler (Eds.), Principles of transgender medicine and surgery (pp. 135-168). Binghamton, NY: Haworth Press.
32. Monstrey, S., Hoebeke, P., Dhont, M., De Cuypere, G., Rubens, R., Moerman, M., et al. (2001). Surgical therapy in transsexual patients: A multi-disciplinary approach. Acta Chirurgica Belgica, 101, 200-209.
33. Moore, E., Wisniewski, A., & Dobs, A. (2003). Endocrine treatment of transsexual people: A review of treatment regimens, outcomes, and adverse effects. Journal of Clinical Endocrinology & Metabolism, 88, 3467-3473.
34. Newfield, E., Hart, S., Dibble, S., & Kohler, L. (2006). Female-to-male transgender quality of life. Quality of Life Research, 15, 1447-1457.
35. O'Hanlan, K. A. (2007). Information for F to M transsexuals: Removal of the uterus (hysterectomy) and the ovaries (oophorectomy). Retrieved June 6, 2007, from http://www.ohanlan.com
36. O'Hanlan, K. A., Dibble, S. L., & Young-Spint, M. (2007). Total laparoscopic hysterectomy for female-to-male transsexuals. Obstetrics & Gynecology, 110, 1096-1101.
37. Okolo, S. (2008). Incidence, etiology, and epidemiology of uterine fibroids. Best Practice & Research Clinical Obstetrics & Gynaecology, 22, 571-588.
38. Pache, T. D., Chadha, S., Gooren, L. J., Hop, W. C., Jaarsma, K.W., Dommerholt, H. B., et al. (1991). Ovarian morphology in long-term androgen-treated female to male transsexuals: A human model for the study of polycystic ovarian syndrome. Histopathology, 5, 445-452.
39. Polson, D. W., Adams, J., Wadsworth, J., & Franks, S. (1988). Polycystic ovaries-a common finding in normal women. Lancet, 1, 870-872.
40. Rachlin, K. (1999). Factors which influence individual's decisions when considering female-to-male genital reconstructive surgery. International Journal of Transgenderism, 3. Retrieved June 16, 2005, from http://www.symposion.com/ijt
41. Rachlin, K. (2002). Transgendered individuals' experiences of psychotherapy. International Journal of Transgenderism, 6. Retrieved June 16, 2005, from http://www.symposion.com/ijt
42. Rachlin, K., Green, J., & Lombardi, E. (2008). Utilization of health care among female-to-male transgender individuals in the United States. Journal of Homosexuality, 54, 243-268.
43. Rhodes, J. C., Kjerulff, K. H., Langenberg, P.W., & Guzinski, G. M. (1999).Hysterectomy and sexual functioning. JAMA, 282, 1934-1941.
44. Ross, R. K., Pike, M. C., Vessey, M. P., Bull, D., Yeates, D., & Casagrande, J. T. (1986). Risk factors for uterine fibroids: Reduced risk associated with oral contraceptives. British Medical Journal, 293, 359-362.
45. Spinder, T., Spijkstra, J. J., van den Tween, J. G., Burger, C. W., van Kessel, H., Hompes, P. G., et al. (1989). The effects of long-term testosterone administration on pulslatile luteinizing hormone secretion and on ovarian histology in eugonadal female-to-male transsexual subjects. Journal of Clinical Endocrinology&Metabolism, 69, 151-157.
46. Van Kesteren, P. J. M., Asscheman, H., Megens, J. A. J., & Gooren, L. J. G. (1997). Mortality and morbidity in transsexual subjects treated with cross-sex hormones. Clinical Endocrinology, 47, 337-342.
47. Wylie, K. (2006). Royal College of Psychiatrists Intercollegiate Standards of Care Committee: Good practice guidelines for the assessment & treatment of gender dysphoria. Retrieved August, 8, 2008, from http://www.rcpsych.ac.uk